Authors
Russell C Coile, K Wiedhaup, Ilva van Bommel, Miriam Mol, Michiel de Vries, EW Massey, J Biller, JN Davis, HP Adams, JR Marler, HN Magnani, A Schotte, PFM Janssen, JE Leysen, ATP Skrabanja, L Flendrig, F van Iren, EWM Schrijnemakers, PJ Reinhoud, JW Kijne, A Knevelman, HJC de Wit, JD de Vries, A Bult, JH Beijnen, ECA van Winden, H Talsma, DJA Crommelin, G Storm, C Oussoren, J Zuidema, MH Vingerhoeds, RHP Smit, F v Dinther, T Hultermans, T Beumer, AN Fransz, H Vromans, DA Bloemhof, FJW van Mansvelt, JRBJ Brouwers, J Raemaekers, RJ Boskma, H Bloemhof, SSN de Graaf, DRA Uges, JGW Kosterink, MWA de Jonge, EF Smit, RAM Kengen, L de Leij, DA Piers, D Shochat, TH The, Gert Luurtsema, Eric Franssen, Geb Visser, Margot Jeronimus-Stratingh, Andries Bruins, Wim Vaalburg, G Luurtsema, J Medema, PH Elsinga, EJF Franssen, GM Visser, W Vaalburg, Jan I Jmker, Donald RA Uges, Hugo van der Paauw, Max Maas, Henk de Vos, Jenny Hettelaar, LML Slolk, W van den Brand, BJ Smit, RME Franssen, AATMM Vinks, DJ Touw, HGM Heijerman, M Danhof, W Bakker, J Hermans, GJ Driessen, R Wolters, IH Go, J Fennis, FWJ Gribnau, Eibert R Heerdink, Hubert G Leufkens, Albert Bakker, ER Heerdink, HS Lau, A Bakker, AJ Porsius, KS Beuning, E Postma-Lim, A de Boer, JE Nagtegaal, N Stecher, MCJM Sturkenboom, LTW de Jong-van den Berg, MC Cornel, BH Ch Stricker, H Wesseling, PMLA van den Bemt, PJM Kil, RHB Meyboom, GHP de Koning, Ron MC Herings, Bruno H Ch Stricker, Hubert GM Leufkens, John Urquhart, Anthonius de Boer, Ferd Sturmans, Alma Middeibeek, Miriam CJM Sturkenboom, Lolkje TW de Jong-van den Berg, MW Lammers, YA Hekster, A Keyser, H Meinardi, WO Renier, H Van Lier, L Veehof, R Stewart, B Mevboom-de Jong, FM Haaijer-Ruskamp, LE Visser, J van der Velden, AHP Paes, JWF van Mil, Th FJ Tromp, MK Casparie, A Kuijpers, PMJ Stuvt, FW Dijkers, CM vd Ree, BA Ruben, HGA Mokkink, D Post, JW Gubbels, LJ Stokx, M Foets, C Florax, A van Dijk, ETJ Peters, GT van der Werf, P Denig, Ellis JC Boerkamp, Flora M Haaijer-Ruskamp
Publication date
1993/12
Journal
Pharmacy World and Science
Volume
15
Pages
K3-K22
Publisher
Kluwer Academic Publishers
Description
Mesna is used as a mucolytic agent in CO, PD* and CF-patients and to prevent chemical cystitis in cancer patients after nigh dose cyclophosphamide of ifosfamide. In urological patients with an" Indianapouch" or" Brickerbladder" mucus formadon is sometimes a serious problem. The use of Mesnz, is a new option in the treatment of these patients. From pilot experiments= it was shown that mesna is an effective mucolytic agent after instillation in the bladder, nevertheless oral dosing will be more convenient
Scholar articles
RC Coile, K Wiedhaup, I van Bommel, M Mol… - Pharmacy World and Science, 1993